Can UnitedHealth Group Stock Crash From Here?
For questions about this article or underlying research, email help@trefis.com.
UnitedHealth Group (UNH) stock returned 24.3% over the past twelve months, compared with 10.3% for the S&P 500. Anyone buying the shares after that run is counting on the insurer’s profits to keep recovering. For that to happen, UnitedHealthcare must keep medical costs in check, and the company has to grow its earnings in 2027. So how far has UnitedHealth Group’s recovery come?

UnitedHealth Group’s Quarterly Margin Is Up From Last Year
The latest quarter shows real progress. UnitedHealth Group’s operating margin was 5.8% in fiscal Q3 2026, ended September 30, up from 3.8% a year earlier. The medical care ratio is the share of premiums spent on care. On the October 13 call, management said it was 88.4% for the quarter, compared with 89.9% a year earlier.
The recovery is not complete, though. Over the twelve months to September 30, the operating margin was 5.3%. That was below the 6.1% margin of the twelve months before. Management also said care intensity remains elevated relative to historical norms.
Can UnitedHealth Group Grow Earnings In 2027?
Management expects so, but has not yet given a 2027 forecast. On the October 13 call, management raised its 2026 outlook to adjusted earnings per share of at least $20.50. The company said analysts’ 2027 estimates may understate the opportunity. It pointed to the lower end of its 13% to 16% long-term earnings growth target as a more reasonable starting point.
The commercial business is the weak spot. Management said medical cost trends there are still running above 11%. It said these pressures will delay its long-term margin targets for that business.
Investors Pay The Market’s P/E For UnitedHealth Group
At the November 17 close, UnitedHealth Group traded at 22.0 times its trailing twelve-month earnings. That is the same multiple as the S&P 500. Those earnings are lower than a year ago. Net income was $15.9 billion over the twelve months to September 30, compared with $17.6 billion in the twelve months before. So buyers are paying the market’s multiple for a year of lower profit, and what they are really paying for is the recovery.
Between February 19 and June 13, 2025, UnitedHealth Group stock fell 54.2% from its April 11 peak to its May 15 low. That fall began after the S&P 500 had already hit its low on April 8, so it was not a market-wide sell-off.
UnitedHealth Group spent a smaller share of premiums on care in its latest quarter. But management has not yet given formal 2027 guidance, and commercial costs remain the weak spot. Management promised a fuller outlook for 2027 before year-end, and the company is expected to report next in January 2027. The commercial cost trend is the number to watch in both.
Betting on one company’s recovery means living with answers that arrive a quarter at a time. That is why we lean on a strategy we are proud of, and we would like to hear about a better one.
Found A Better Strategy? We’d Love To Learn.
Ours is the Trefis High Quality (HQ) Portfolio: 30 quality stocks in equal weight. Since its September 2020 launch it has returned more than 105%, ahead of a benchmark that combines the S&P 500, S&P MidCap and Russell 2000. If yours has done better, tell us about it. If not, come take a look.
Spot an error or want more like this? Tell us in 10 seconds.